+49 431 800 147 0
info@healthcareheads.com
Reimbursement and Market Access Support

We navigate you through the healthcare market.

Consultancy for medical device companies to support Market Access of innovative medical products.

Market Access

What is needed for a successful Market Access in Germany?

Reimbursement

How are therapies in the healthcare system reimbursed?

Economics

Hospital economics vs. Health economics?

Evidence

What kind of evidence is needed for your goals?

External Affairs

Who are the relevant stakeholders in the healthcare system?
Who we are

 

Healthcare Heads specializes in delivering tailored consultancy services in Reimbursement and Market Access exclusively designed for medical companies targeting the German healthcare market.

Our mastery of Market Access spans across pivotal areas encompassing Reimbursement, Economics, Evidence and External Affairs. These key focal points empower us to provide you with holistic and all-encompassing solutions.

Distinguished by an unparalleled fusion of expertise and an extensive track record within the German healthcare realm, we stand as your foremost partner in shaping Reimbursement and Market Access strategies and ensuring their seamless operational integration.

In collaboration with you, we surmount barriers that impede market entry, unlocking pathways to connect your pioneering technology with a broader spectrum of patients. Let us embark on this journey together, unraveling the full potential of your innovation.

E-Mail: info@healthcareheads.com

Phone: +49 431 800 147 0

 

New 2025 calculations for German hybrid DRGs

The InBA's extended evaluation committee published key decisions on the calculation of hybrid DRGs.

Ready for the 2026 NUB application procedure?

Now is the time to get ready for the 2026 NUB application round!

The InEK publishes the 2025 results of the NUB applications for ATMP

Four medical ATMP methods received “NUB status 1”.

Electronic prescription (e-prescription) of digital health apps (DiGA): launch in Germany in 2026 at the earliest

The introduction of e-prescriptions for DiGA has been delayed. The Federal Association of Physicians of the Statuary Health Insurances (KBV) and the Umbrella Organization of the Statutory Health Insurances (GKV-Spitzenverband) expect the nationwide…

Market access for med-tech in Germany

Innovations need clarity on regulations and reimbursement.

Understanding the changes in German health policies

What do med-tech decision-makers need to know about the current regulations in Germany.

[Translate to Englisch:]

In 2025 the German State Prime Rates (LBFW) saw the first year to date adjustment

The new Healthcare Heads data portal keeps you up-to-date at all times - transparent, data-supported and at the click of a button.

Strategic reimbursement in the German healthcare market

With Healthcare Heads to a sustainable market strategy in the German healthcare market.

Amendment to German medical fee schedules (GOÄ)

On May-29th 2025, the 129th German Medical Assembly confirmed the amended version of the GOÄ.

Subscribe to the Healthcare Heads newsletter

with topics of Market Access and Reimbursement in Germany.

Don't miss any of the latest developments and be among the first to receive relevant information from the areas of market access and reimbursement in Germany.

Privacy policy

Link to our Privacy Policy >>

Marketing von